|
|
Software
eScreen123
MyeScreen.com
MRO Software
Products
Paperless CCF and ePad
eCup
eReader
mCup and mCheck
Services
The EOHN
Documents
Features and Benefits
Validation Study
Speak to an eScreen Representative (800) 881.0722, option 7
Contact Us
|
|
Documents :: Validation Study
Validation Study
Evaluation of the eScreen eCup Drugs of Abuse Screening Device: Correlation with EMITII and GC/MS.
The eCup Drugs of Abuse screening system is a urine collection device and immunochromatographic assay. The assay provides a rapid test system with the eScreen eReader to provide qualitative results within 8 minutes or less using SAMHSA cutoff concentrations. eScreen assays for Amphetamine (as Methamphetamine), Cannabinoids (THC), Cocaine Metabolite (as Benzoylecgonine), Opiates (as Morphine), and PCP (Phencyclidine) were evaluated in this study.
Qualitative drug screening results obtained by an independent study of testing clinical samples with eCup Drugs of Abuse Screening Device were compared to qualitative results obtained by EMIT II (Syva, Dade Behring).
All Positive eScreen and EMIT II results were confirmed by GC/MS (Gas Chromatography/Mass Spectrometry).
Results show the eCup Drugs of Abuse Screening Device for the rapid qualitative detection of Amphetamines, Cannabinoids (THC), Cocaine Metabolite, Opiates and PCP can provide accurate and reliable screening results in urine when compared to a SAMHSA laboratory.
To request a copy of this Validation Study please contact eScreen.
Performed by: Derek P. Baker DP Baker and Associates Agoura Hills, California 91301
|
|
|